Holding or stepping back your GLP-1 dose
Going up isn't the only direction. Why people hold a dose or step back a level on a GLP-1 — and how to keep the record straight.
The standard GLP-1 schedule moves in one direction: up. But real titration isn’t always a straight climb. Sometimes the right move is to hold a dose for a while, or step back a level — and that’s a normal part of the process, not a setback.
Why hold a dose
A step-up that brings rough side effects is your body asking for more time. Many prescribers will keep you at your current dose for an extra few weeks rather than push through. Holding lets the side effects settle while you keep the benefit you’ve already got.
Why step back
If a higher dose is genuinely hard to tolerate, dropping back a level is often better than white-knuckling it — or quitting. A dose you can live with and stay consistent on beats a higher one you dread.
Keep the record honest
Holds and step-backs are exactly where dose history gets muddled. Six weeks later, “what am I actually on?” is a real question. Logging each change — the date, the new level, the reason — means you and your prescriber always have an accurate picture, whether you’re on Ozempic, Mounjaro, Zepbound, or a compounded version.
A tracker built for this shows your current dose and how long you’ve held it, and lets you record a step-back without it looking like a mistake.
This is guidance from your prescriber, not the app
When and whether to hold or step back is a clinical decision. Lirea doesn’t advise a dose — it just keeps an accurate, private record of the one you’re on, encrypted on your device.
Up, hold, or back — what matters is that the record matches reality.
Track the change, not just the climb, and your titration stays clear in every direction.